Literature DB >> 33829975

Aortic Regurgitation as a Complication of Electrophysiologic Ablation Techniques: A Narrative Review.

Esraa Shehata1, Mohamed Samy Abdel-Samie2, Ahmad Elkoumy3, Ahmed Yehia4, Osama Soliman5, Mohammad Abdelghani6.   

Abstract

BACKGROUND: Radiofrequency catheter ablation is a well-established treatment for several cardiac arrhythmias. Arrhythmias originating from the left side of the heart including ventricular and supraventricular tachycardia and ectopy can be successfully ablated through either transseptal or retrograde aortic approach. Although these techniques have a generally low rate of complications, aortic valve injury is a potential complication of ablation at the left cardiac side that warrants more investigation.
OBJECTIVE: The purpose of this review is to evaluate the incidence of iatrogenic aortic valve regurgitation and explore the potential mechanisms and risk factors that might contribute to aortic valve injury during radiofrequency ablation. Additionally, the course and progression of aortic regurgitation in the reported cases will be described.
METHODS: Authors searched PubMed for articles using the keywords "ablation" AND "aortic insufficiency" OR "aortic valve injury" OR "aortic regurgitation". Case reports and series as well as retrospective and prospective studies were included, and relevant review articles and editorial comments were used as a supplementary source of data. A total of 19 references were used and a detailed description of patient characteristics, procedural techniques, and incidence, predictors, and fate of aortic regurgitation were reported by 11 clinical studies.
RESULTS: There is a small risk of significant iatrogenic aortic regurgitation after radiofrequency ablation of left-sided cardiac arrhythmias, especially techniques performed via a retrograde aortic approach.
CONCLUSION: Although the risk is not confined to procedures applying direct energy to the aortic cusp region, a more aggressive ablation applied in the vicinity of the valvular complex seems to be associated with a higher risk. Routine post-procedural surveillance should be adopted to detect de novo aortic valve injury following radiofrequency ablation techniques. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Aortic regurgitation; aortic insufficiency; aortic valve injury; arrhythmia; radiofrequency ablation; tachycardias.

Mesh:

Year:  2021        PMID: 33829975      PMCID: PMC8950496          DOI: 10.2174/1573403X17666210408093447

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


  21 in total

1.  Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation.

Authors:  Feifan Ouyang; Jian Ma; Siew Yen Ho; Dietmar Bänsch; Boris Schmidt; Sabine Ernst; Karl-Heinz Kuck; Shaowen Liu; He Huang; Min Chen; Julian Chun; Yunlong Xia; Kazuhiro Satomi; Huimin Chu; Shu Zhang; Matthias Antz
Journal:  J Am Coll Cardiol       Date:  2006-06-12       Impact factor: 24.094

2.  Electrophysiologic and histologic observations of chronic atrioventricular block induced by closed-chest catheter desiccation with radiofrequency energy.

Authors:  S K Huang; S Bharati; M Lev; F I Marcus
Journal:  Pacing Clin Electrophysiol       Date:  1987-07       Impact factor: 1.976

3.  Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation.

Authors:  Feifan Ouyang; Parwis Fotuhi; Siew Yen Ho; Joachim Hebe; Marius Volkmer; Masahiko Goya; Mark Burns; Matthias Antz; Sabine Ernst; Riccardo Cappato; Karl Heinz Kuck
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

Review 4.  Idiopathic ventricular arrhythmias: Relevance to the anatomy, diagnosis and treatment.

Authors:  Takumi Yamada
Journal:  J Cardiol       Date:  2016-07-09       Impact factor: 3.159

5.  Aortic Valve Rupture Due to Radiofrequency Ablation of Left Ventricular Outflow Tract Extrasystole.

Authors:  Zsuzsanna Kis; Matyas Pal; Zoltan Szabo; Attila Kardos
Journal:  J Cardiovasc Electrophysiol       Date:  2016-04-05

6.  Low incidence of significant valvar insufficiency following retrograde aortic radiofrequency catheter ablation in young patients.

Authors:  P A Frias; M B Taylor; A Kavanaugh-McHugh; F A Fish
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

7.  Prevalence, risk, and benefits of radiofrequency catheter ablation at the aortic cusp for the treatment of mid- to anteroseptal supra-ventricular tachyarrhythmias.

Authors:  Junbeom Park; Jin Wi; Boyoung Joung; Moon Hyoung Lee; Young-Hoon Kim; Chun Hwang; Hui-Nam Pak
Journal:  Int J Cardiol       Date:  2012-03-28       Impact factor: 4.164

8.  Frequency and long term follow up of valvar insufficiency caused by retrograde aortic radiofrequency catheter ablation procedures.

Authors:  A Olsson; B Darpö; L Bergfeldt; M Rosenqvist
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

9.  Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva.

Authors:  Takumi Yamada; Yung R Lau; Silvio H Litovsky; H Thomas McElderry; Harish Doppalapudi; Jose Osorio; Vance J Plumb; G Neal Kay
Journal:  Heart Rhythm       Date:  2013-08-20       Impact factor: 6.343

10.  Safety of radiofrequency catheter ablation without coronary angiography in aortic cusp ventricular arrhythmias.

Authors:  Kurt S Hoffmayer; Thomas A Dewland; Henry H Hsia; Nitish Badhwar; Jonathan C Hsu; Zian H Tseng; Gregory M Marcus; Melvin M Scheinman; Edward P Gerstenfeld
Journal:  Heart Rhythm       Date:  2014-04-13       Impact factor: 6.343

View more
  1 in total

1.  Complications of catheter ablation for ventricular tachycardia.

Authors:  Aishwarya Pastapur; Daniel McBride; Amrish Deshmukh; Stefanie Driesenga; Michael Ghannam; Frank Bogun; Jackson J Liang
Journal:  J Interv Card Electrophysiol       Date:  2022-09-02       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.